Noguera SMF, Karchmer KS, EsliRabadán MC, Sánchez PA

Language: Spanish
References: 10
Page: 47-51
PDF size: 245.19 Kb.

ABSTRACT

Influenza A H1N1 is an acute respiratory illness caused by a new strain of H1N1. Human influenza is a subtype of influenza A virus, from the family of Orthomyxoviridae. This strain is the cause of new influenza pandemic declared by the World Health Organization in June, 2009. This paper reports the first case occurred in Mexico: a 39-year-old woman with a history of diabetes mellitus type 2 and obesity grade II, which suffered atypical and aggressive pneumonia positive to coronavirus. Patient died 98 hours after her admission to the hospital unit. Due to the clinical presentation of the case, the doctors sent samples to the Instituto Nacional de Diagnóstico y Referencia Epidemiológica that sent an aliquot of the National Center for Immunization and Respiratory Diseases of the Agency of Public Health in Canada, that reported positivity to influenza virus, and catalogued it as a new global strain called influenza A virus H1N1. The notice of 229E/NL63 coronavirus and its relationship to the recent outbreaks of avian influenza in humans and the clinical presentation of the case were the epidemiological circumstances that prevented the nation epidemiology system to establish global containment strategies to prevent the spread of this emerging infection. The consequence was the declaration of WHO pandemic alert level 6. Its behavior in pregnancy, reported by Assistant General Direction of Epidemiology in Mexico, has placed this infection as a risk factor for women.

REFERENCES

1. Baden LR, Drazen JM, Kritek PA ,Curfman GD, et al. H1N1 influenza A disease. Information for Health Professionals. N Engl J Med 2009;360:2666-2667.

2. CDC. Swine influenza A H1N1 infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009;58:400-402.

3. Malik JS, Poona LM, Guana Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus. J Clin Virol 2009;45:169-173.

4. Pearson H. Mystery slow virus to yield its identity as patient numbers rise. Nature 2003;422(364):423-424. Disponible en: http://www.nature.com/nature/journal/v422/n6930/pdf/422364b.pdf

5. World Health Organization. Alert, verification and public health management of SARS in the post-outbreak period. Disponible en www.who.int/csr/sars/postoutbreak/en/

6. Álvarez SB, Álvarez LF, Jordá R, Serra J, et al. Factores pronósticos y etiología de los pacientes con neumonía comunitaria grave ingresados en UCI. Estudio multicéntrico español. Med Clínica 1998;111(17):650-654.

7. Consenso Mexicano de Diagnóstico y Tratamiento de las Neumonías: Un Consenso Nacional de Expertos. México: Dresde Editorial Médica; 2002.

8. Álvarez-Martínez CJ. Neumonía adquirida en la comunidad. Inf Ter Sist Nac Salud 2003;27(1):1-10.

9. Franco-Paredes C, Kuri-Morales P, Álvarez-Lucas C, Palacios- Zavala E, et al. Síndrome agudo respiratorio severo: un panorama mundial de la epidemia. Salud Publica Mex 2003;45(3):211-220. Disponible en http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S00363634200300030001 1&lng=es&nrm=i&tlng=es

10. Gallardo CJ, Castelao NJ, Izquierdo JL, Sánchez HI, Carrillo AF. Neumonía adquirida en la comunidad: diagnóstico y puesta al día en el tratamiento. Revista de Patología Respiratoria 2001;4(4):156-161.